Log in
Enquire now
‌

US Patent 10231938 Transdermal drug delivery device including an occlusive backing

Patent 10231938 was granted and assigned to Noven Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Noven Pharmaceuticals
Noven Pharmaceuticals
0
Current Assignee
Noven Pharmaceuticals
Noven Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102319380
Patent Inventor Names
Viet Nguyen0
David Kanios0
Juan A. Mantelle0
Date of Patent
March 19, 2019
0
Patent Application Number
148517640
Date Filed
September 11, 2015
0
Patent Citations Received
‌
US Patent 11976026 Amphetamine carbamate compounds and methods
0
‌
US Patent 11559501 Transdermal amphetamine compositions with low levels of carbamate
‌
US Patent 11572339 Amphetamine carbamate compounds and methods
Patent Primary Examiner
‌
Robert A Wax
0
Patent abstract

A transdermal drug delivery system for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric backing layer which can control the delivery rate and profile of the transdermal drug delivery system by adjusting the moisture vapor transmission rate of the polymeric backing layer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10231938 Transdermal drug delivery device including an occlusive backing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.